|
Genmark Diagnostics Inc (GNMK) |
|
|
|
Genmark Diagnostics Inc 's Revenue per Employee
Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales
With a revenue increase of 84.14% in the forth quarter 2020, year on year to cumulative value of $172 million, Genmark Diagnostics Inc 's revenue per employee grew on a trailing twelve months basis to $ 480,543, this marks a new company high. Within the Healthcare sector Employees of 78 other companies have achieved higher revenue per employee. While Genmark Diagnostics Inc 's total ranking has deteriorated compared to the previous quarter from 0 to 1101. Genmark Diagnostics Inc has 357 employees.
What is Sales per Employee Ratio?
Select the Comparisons :
|
|
Select the Ratio:
|
|
GNMK Revenue per Employee |
(Dec 31 2020) IV. Quarter |
(Sep 30 2020) III. Quarter |
(Jun 30 2020) II. Quarter |
(Mar 31 2020) I. Quarter |
(Dec 31 2019) IV. Quarter |
Y / Y Revenue Change |
84.14 % |
103.87 % |
118.17 % |
79.92 % |
40.34 % |
Sales per Employee
(TTM) $ |
480,543 |
416,443 |
355,580 |
294,762 |
246,557 |
GNMK's Total
Ranking |
# 1101 |
# 0 |
# 0 |
# 0 |
# 0 |
Seq. Revenue Change |
17.43 % |
6.39 % |
3.47 % |
42.45 % |
30.01 % |
Revenue per Employee Statistics |
High |
Average |
Low |
$ 480,543 |
$ 176,961 |
$ 45,367 |
(Dec 31 2020) |
|
(March 31, 2015) |
Date modified: -0001-11-30T00:00:00+00:00
Companies with similar Revenue per Employee for 12 months ending Dec 31 2020, within Healthcare Sector | Revenue per Employee | Revenue 12 months ending Dec 31 2020 | Number of Employees Dec 31 2020 | Regeneron Pharmaceuticals Inc | 819,550.54 | $ 8,497.100 Million | 10,368 | Patterson Companies Inc | 805,247.71 | $ 5,636.734 Million | 7,000 | Merck and Co Inc | 705,794.12 | $ 47,994.000 Million | 68,000 | Eli Lilly And Company | 701,137.14 | $ 24,539.800 Million | 35,000 | Adamas Pharmaceuticals Inc | 620,508.33 | $ 74.461 Million | 120 | Hologic Inc | 603,931.45 | $ 4,193.700 Million | 6,944 | Pfizer Inc | 603,088.61 | $ 47,644.000 Million | 79,000 | Johnson and Johnson | 582,808.75 | $ 82,584.000 Million | 141,700 | Zoetis Inc | 551,652.89 | $ 6,675.000 Million | 12,100 | Ptc Therapeutics inc | 543,951.43 | $ 380.766 Million | 700 | Abiomed Inc | 529,255.21 | $ 812.936 Million | 1,536 | Henry Schein Inc | 468,478.75 | $ 10,119.141 Million | 21,600 | Biolife Solutions Inc | 466,864.08 | $ 48.087 Million | 103 | Resmed Inc | 455,811.64 | $ 3,719.423 Million | 8,160 | Intuitive Surgical Inc | 445,052.59 | $ 4,358.400 Million | 9,793 | Caredx Inc | 430,928.25 | $ 192.194 Million | 446 | Orthofix Medical Inc | 406,562.00 | $ 406.562 Million | 1,000 | Galapagos Nv | 374,681.15 | $ 535.419 Million | 1,429 | Heska Corporation | 368,732.47 | $ 199.853 Million | 542 | Zimmer Biomet Holdings Inc | 360,230.77 | $ 7,024.500 Million | 19,500 | Carlisle Companies Incorporated | 353,766.67 | $ 4,245.200 Million | 12,000 | Meridian Bioscience Inc | 351,956.47 | $ 299.163 Million | 850 | 3m Company | 338,778.95 | $ 32,184.000 Million | 95,000 | Inspire Medical Systems inc | 332,510.09 | $ 115.381 Million | 347 | Illumina Inc | 330,510.20 | $ 3,239.000 Million | 9,800 | Bio rad Laboratories Inc | 322,231.14 | $ 2,545.626 Million | 7,900 | Stryker Corp | 311,978.26 | $ 14,351.000 Million | 46,000 | Abbott Laboratories | 306,265.49 | $ 34,608.000 Million | 113,000 | Dexcom Inc | 305,825.40 | $ 1,926.700 Million | 6,300 | Agilent Technologies inc | 305,524.86 | $ 5,530.000 Million | 18,100 |
|